Exothera
Dmitry Sorokin is currently working at EXOTHERA as Development technology transfer lead and Drug product development engineer. Prior to this role, Dmitry worked at R-Pharm for several years, where he held various positions including Head of therapeutic protein manufacturing site, Biotechnology engineer, QA specialist, and Laboratory assistant. Dmitry studied Biology at Yaroslavl Demidov State University and also participated in an exchange program at the University of Vermont.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660